Description
This opportunity, announced by the National Institutes of Health, aims to support the discovery, preclinical development, and proof of concept testing of new treatments for mental disorders, substance use disorders, or alcohol use disorder. It encourages partnerships between academia and industry. The grant will support discrete, specified projects performed by named investigators in areas representing their specific interests and competencies. Key aspects of the work include advancing rationally based candidate agents and neurostimulation approaches, developing novel ligands and circuit-engagement devices, and further characterizing existing or validating new drug/device targets.
• The grant supports projects for the treatment of mental disorders, substance use disorders, or alcohol use disorder.
• Partnerships between academia and industry are strongly encouraged.
• The grant uses the U01 mechanism, supporting a discrete, specified project.
• The project should be performed by named investigators in an area of their specific interest and competency.
• The goal is to advance the discovery, preclinical development, and proof of concept testing of new candidate agents and approaches.
• Developing novel tools for further characterization of existing or validation of new drug/device targets is also a focus.